Vorolazan Intermediate is a key ingredient in the synthesis of Vorolazan, a potent and selective potassium-competitive acid blocker used to treat gastroesophageal reflux disease (GERD) and other acid-related diseases. This intermediate compound is a key component in the production of Vorolazan and is vital to the pharmaceutical industry. Vorolazan intermediates have high purity and precise chemical structure, making them suitable for R&D and large-scale production. Our products undergo strict quality control measures to ensure their consistency and reliability, making them ideal for pharmaceutical manufacturers and researchers. This compound is highly valued in the pharmaceutical industry as it plays a key role in the synthesis of Vorolazan, a breakthrough drug for the treatment of acid-related diseases. As Vorolazan continues to gain recognition for its effectiveness in the management of gastroesophageal reflux disease and related conditions, demand for Vorolazan intermediates is rising. JDK owns the first-class production facilities and Quality management equipments, which assures the stable supply of API intermediates. Professional team assure R&D of the product. Against both, we are searching for CMO & CDMO in domestic and international market.